[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100522398":3},{"organization":4,"outcomesModule":7,"designInfo":13,"detailedDescription":11,"studyPopulation":11,"armGroups":19,"interventions":31,"overallOfficials":11,"centralContacts":46,"locations":52,"responsibleParty":285,"collaborators":11,"id":287,"slug":11,"hasResults":288,"nctId":289,"briefTitle":290,"officialTitle":291,"acronym":11,"eligibilityCriteria":292,"healthyVolunteers":288,"sex":293,"minAge":294,"maxAge":11,"enrollmentInfo":295,"targetDuration":11,"studyType":298,"phases":299,"briefSummary":301,"conditions":302,"keywords":11,"overallStatus":55,"whyStopped":11,"lastUpdateSubmitDate":304,"lastUpdatePostDateStruct":305,"startDateStruct":308,"completionDateStruct":310,"leadSponsor":312,"locationsCount":313},{"fullName":5,"class":6},"Beijing InnoCare Pharma Tech Co., Ltd.","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"IRC-assessed PFS",null,"Through study completion, an average of 5 year.",{"allocation":14,"interventionModel":15,"interventionModelDescription":11,"primaryPurpose":16,"observationalModel":11,"timePerspective":11,"maskingInfo":17},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":18,"maskingDescription":11,"whoMasked":11},"NONE",[20,26],{"label":21,"type":22,"description":11,"interventionNames":23},"Orelabrutinib","EXPERIMENTAL",[24,25],"Drug: Orelabrutinib","Drug: Rituximab",{"label":27,"type":28,"description":11,"interventionNames":29},"Comparator","ACTIVE_COMPARATOR",[30,25],"Drug: Lenalidomide",[32,36,40,44],{"type":33,"name":21,"description":34,"armGroupLabels":35,"otherNames":11},"DRUG","Orelabrutinib Tablets",[21],{"type":33,"name":37,"description":38,"armGroupLabels":39,"otherNames":11},"Rituximab","Rituximab Injection",[21],{"type":33,"name":41,"description":42,"armGroupLabels":43,"otherNames":11},"Lenalidomide","Lenalidomide Capsules",[27],{"type":33,"name":37,"description":38,"armGroupLabels":45,"otherNames":11},[27],[47],{"name":48,"role":49,"phone":50,"phoneExt":11,"email":51},"Alexia Lu","CONTACT","010-66609745","CO_HGRAC@innocarepharma.com",[53,70,83,92,105,114,127,135,148,162,175,184,197,208,221,233,246,259,272],{"facility":54,"status":55,"city":56,"state":57,"zip":58,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"The First Affiliated Hospital of Bengbu Medical College","RECRUITING","Bengbu","Auhui","233000","China","CN",{"type":62,"coordinates":63},"Point",[64,65],117.36083,32.94083,{"lat":65,"lon":64},[68],{"name":69,"role":49,"phone":11,"phoneExt":11,"email":11},"Yanli Yang",{"facility":71,"status":55,"city":72,"state":73,"zip":74,"country":59,"countryCode":60,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"Beijing Tiantan Hospital, Capital Medical University","Beijing","Beijing Municipality","100070",{"type":62,"coordinates":76},[77,78],116.39723,39.9075,{"lat":78,"lon":77},[81],{"name":82,"role":49,"phone":11,"phoneExt":11,"email":11},"Lin Fu",{"facility":84,"status":55,"city":72,"state":73,"zip":85,"country":59,"countryCode":60,"cosmosGeoPoint":86,"geoPoint":88,"contacts":89},"Beijing Tongren Hospital, Capital Medical University","100730",{"type":62,"coordinates":87},[77,78],{"lat":78,"lon":77},[90],{"name":91,"role":49,"phone":11,"phoneExt":11,"email":11},"Liang Wang",{"facility":93,"status":55,"city":94,"state":95,"zip":96,"country":59,"countryCode":60,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"Sun Yat-sen University Cancer Center","Guangzhou","Guangdong","510055",{"type":62,"coordinates":98},[99,100],113.25,23.11667,{"lat":100,"lon":99},[103],{"name":104,"role":49,"phone":11,"phoneExt":11,"email":11},"Huiqiang Huang",{"facility":106,"status":55,"city":94,"state":95,"zip":107,"country":59,"countryCode":60,"cosmosGeoPoint":108,"geoPoint":110,"contacts":111},"Guangdong Provincial Hospital of Chinese Medicine","510120",{"type":62,"coordinates":109},[99,100],{"lat":100,"lon":99},[112],{"name":113,"role":49,"phone":11,"phoneExt":11,"email":11},"Xiping Dai",{"facility":115,"status":55,"city":116,"state":117,"zip":118,"country":59,"countryCode":60,"cosmosGeoPoint":119,"geoPoint":123,"contacts":124},"Henan Cancer Hospital","Zhengzhou","Henan","450003",{"type":62,"coordinates":120},[121,122],113.64861,34.75778,{"lat":122,"lon":121},[125],{"name":126,"role":49,"phone":11,"phoneExt":11,"email":11},"Keshu Zhou",{"facility":128,"status":55,"city":116,"state":117,"zip":118,"country":59,"countryCode":60,"cosmosGeoPoint":129,"geoPoint":131,"contacts":132},"Henan Provincial Peoples Hospital",{"type":62,"coordinates":130},[121,122],{"lat":122,"lon":121},[133],{"name":134,"role":49,"phone":11,"phoneExt":11,"email":11},"Zunmin Zhu",{"facility":136,"status":55,"city":137,"state":138,"zip":139,"country":59,"countryCode":60,"cosmosGeoPoint":140,"geoPoint":144,"contacts":145},"Union Hospital Tongji Medical College Huazhong University of Science and Technology","Wuhan","Hubei","430000",{"type":62,"coordinates":141},[142,143],114.26667,30.58333,{"lat":143,"lon":142},[146],{"name":147,"role":49,"phone":11,"phoneExt":11,"email":11},"Yu Hu",{"facility":149,"status":150,"city":151,"state":152,"zip":153,"country":59,"countryCode":60,"cosmosGeoPoint":154,"geoPoint":158,"contacts":159},"Hunan Cancer Hospital","NOT_YET_RECRUITING","Changsha","Hunan","410000",{"type":62,"coordinates":155},[156,157],112.97087,28.19874,{"lat":157,"lon":156},[160],{"name":161,"role":49,"phone":11,"phoneExt":11,"email":11},"Yajun Li",{"facility":163,"status":55,"city":164,"state":165,"zip":166,"country":59,"countryCode":60,"cosmosGeoPoint":167,"geoPoint":171,"contacts":172},"The First Affiliated Hospital of Nanchang University","Nanchang","Jiangxi","330006",{"type":62,"coordinates":168},[169,170],115.85306,28.68396,{"lat":170,"lon":169},[173],{"name":174,"role":49,"phone":11,"phoneExt":11,"email":11},"Fei Li",{"facility":176,"status":55,"city":164,"state":165,"zip":177,"country":59,"countryCode":60,"cosmosGeoPoint":178,"geoPoint":180,"contacts":181},"Jiangxi Cancer Hospital","330029",{"type":62,"coordinates":179},[169,170],{"lat":170,"lon":169},[182],{"name":183,"role":49,"phone":11,"phoneExt":11,"email":11},"Wuping Li",{"facility":185,"status":55,"city":186,"state":187,"zip":188,"country":59,"countryCode":60,"cosmosGeoPoint":189,"geoPoint":193,"contacts":194},"The Second Hospital of Dalian Medical University","Dalian","Liaoning","116023",{"type":62,"coordinates":190},[191,192],121.60222,38.91222,{"lat":192,"lon":191},[195],{"name":196,"role":49,"phone":11,"phoneExt":11,"email":11},"Xiaojing Yan",{"facility":198,"status":55,"city":199,"state":187,"zip":200,"country":59,"countryCode":60,"cosmosGeoPoint":201,"geoPoint":205,"contacts":206},"The first Hospital of China Medical University","Shenyang","110002",{"type":62,"coordinates":202},[203,204],123.43278,41.79222,{"lat":204,"lon":203},[207],{"name":196,"role":49,"phone":11,"phoneExt":11,"email":11},{"facility":209,"status":150,"city":210,"state":211,"zip":212,"country":59,"countryCode":60,"cosmosGeoPoint":213,"geoPoint":217,"contacts":218},"The Affiliated Hospital Of Qingdao University","Qingdao","Shandong","266000",{"type":62,"coordinates":214},[215,216],120.38042,36.06488,{"lat":216,"lon":215},[219],{"name":220,"role":49,"phone":11,"phoneExt":11,"email":11},"Xia Zhao",{"facility":222,"status":55,"city":223,"state":211,"zip":224,"country":59,"countryCode":60,"cosmosGeoPoint":225,"geoPoint":229,"contacts":230},"Yantai Yuhuangding Hospital","Yantai","264099",{"type":62,"coordinates":226},[227,228],121.44081,37.47649,{"lat":228,"lon":227},[231],{"name":232,"role":49,"phone":11,"phoneExt":11,"email":11},"Xiaoxia Chu",{"facility":234,"status":55,"city":235,"state":236,"zip":237,"country":59,"countryCode":60,"cosmosGeoPoint":238,"geoPoint":242,"contacts":243},"Fudan University Shanghai Cancer Center","Shanghai","Shanghai Municipality","200040",{"type":62,"coordinates":239},[240,241],121.45806,31.22222,{"lat":241,"lon":240},[244],{"name":245,"role":49,"phone":11,"phoneExt":11,"email":11},"Yan Yuan",{"facility":247,"status":55,"city":248,"state":249,"zip":250,"country":59,"countryCode":60,"cosmosGeoPoint":251,"geoPoint":255,"contacts":256},"The Second Affiliated Hospital of Xi'an Jiaotong University（Xibei Hospital）","Xi’an","Shanxi","710004",{"type":62,"coordinates":252},[253,254],113.52486,35.99785,{"lat":254,"lon":253},[257],{"name":258,"role":49,"phone":11,"phoneExt":11,"email":11},"Wanhong Zhao",{"facility":260,"status":150,"city":261,"state":262,"zip":263,"country":59,"countryCode":60,"cosmosGeoPoint":264,"geoPoint":268,"contacts":269},"West China Hospital, Sichuan University","Chengdu","Sichuan","610041",{"type":62,"coordinates":265},[266,267],104.06667,30.66667,{"lat":267,"lon":266},[270],{"name":271,"role":49,"phone":11,"phoneExt":11,"email":11},"Liqun Zou",{"facility":273,"status":55,"city":274,"state":275,"zip":276,"country":59,"countryCode":60,"cosmosGeoPoint":277,"geoPoint":281,"contacts":282},"The First Affiliated Hospital of Zhejiang University School of Medicine","Hangzhou","Zhejiang","310003",{"type":62,"coordinates":278},[279,280],120.16142,30.29365,{"lat":280,"lon":279},[283],{"name":284,"role":49,"phone":11,"phoneExt":11,"email":11},"Wenjuan Yu",{"type":286,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100522398",false,"NCT06082102","Efficacy and Safety of Orelabrutinib Combined With Rituximab Versus Lenalidomide Combined With Rituximab in Patients With Relapsed\u002FRefractory Marginal Zone Lymphoma","A Randomized, Controlled, Open-label, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Orelabrutinib Plus Rituximab Versus Lenalidomide Plus Rituximab in Relapsed\u002FRefractory Marginal Zone Lymphoma","Inclusion Criteria:\n\n1. Age ≥ 18 years , either sex.\n2. Histopathologically confirmed B-cell non-Hodgkin lymphoma MZL (splenic, nodal, or extra-nodal).\n3. Prior systemic therapy including at least one anti-CD20 monoclonal antibody-containing regimen is required, with the following specifications:\n\n   For combination therapies: Minimum of 2 completed treatment cycles For anti-CD20 monotherapy: Minimum of 4 administered doses Progression during treatment waives cycle\u002Fdose requirements\n4. Relapsed or refractory disease.\n5. At least 1 measurable lesion confirmed through enhanced computed tomography (CT) or enhanced magnetic resonance imaging (MRI).\n6. ECOG performance status (PS) score of 0-2.\n\nExclusion Criteria:\n\n1. Administration of the specified anti-tumor therapies within 2 weeks prior to the first dose of the study treatment.\n2. Administration of any other investigational product within 4 weeks prior to the first dose of the study treatment, or concurrent participation in another clinical trial.(Excluding patients who have discontinued treatment and are in long-term follow-up).\n3. Prior treatment with any types of BTK inhibitor.\n4. Patients refractory to lenalidomide plus rituximab (R2 regimen). Refractoriness is defined as either: Failure to achieve at least partial response (PR) after completing an adequate R2 treatment course (≥2 cycles at standard doses), OR Disease progression during R2 therapy or within 6 months after the last dose.\n5. Central nervous system (CNS) lymphoma, and lymphoma with CNS or meningeal involvements.","ALL","18 Years",{"count":296,"type":297},324,"ESTIMATED","INTERVENTIONAL",[300],"PHASE3","Efficacy and Safety of Orelabrutinib Combined with Rituximab versus Lenalidomide Combined with Rituximab in Patients with Relapsed\u002FRefractory Marginal Zone Lymphoma",[303],"Relapsed\u002FRefractory Marginal Zone Lymphoma","2025-09-12",{"date":306,"type":307},"2025-09-15","ACTUAL",{"date":309,"type":307},"2023-12-19",{"date":311,"type":297},"2030-02-25",{"name":5,"class":6},19]